The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients.

Autor: Gostelie R; University Medical Center, Utrecht University, Utrecht, The Netherlands., Stegeman I; Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center, Utrecht University, Utrecht, The Netherlands., Berkers G; Department of Pediatric Respiratory Medicine and Allergology, Cystic Fibrosis Center, University Medical Center, Utrecht University, Utrecht, The Netherlands., Bittermann J; Department of Pediatric Otorhinolaryngology, University Medical Center, Utrecht University, Utrecht, The Netherlands., Ligtenberg-van der Drift I; Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center, Utrecht University, Utrecht, The Netherlands., Kipshagen PV; Department of Otorhinolaryngology, Beatrix Hospital, Gorinchem, The Netherlands., de Winter-de Groot K; Department of Pediatric Respiratory Medicine and Allergology, Cystic Fibrosis Center, University Medical Center, Utrecht University, Utrecht, The Netherlands., Speleman L; Department of Pediatric Otorhinolaryngology, University Medical Center, Utrecht University, Utrecht, The Netherlands.

Publikováno v: PloS one [PLoS One] 2020 Jul 20; Vol. 15 (7), pp. e0235638. Date of Electronic Publication: 2020 Jul 20 (Print Publication: 2020).